Abstract
Objective To investigate the role of endoscopic retrograde cholangiopancreatography （ERCP） management in the diagnosis and treatment and illustrate clinical features of non-iatrogenic hemobilia. Methods A total of 35 patients diagnosed as hemobilia via endoscope from August 2009 to September 2012 were reviewed retrospectively. Patients with iatrogenic causes of hemobilia were excluded in this study. Results The clinical features of hemobilia mainly included jaundice （77. 1% ）, abdominal pain （62. 9% ） , hematemesis （5. 7% ） , melena （2. 9% ） and bematoehezia （2.9%）. Qnincke triad was found in 4 patients with hemobilia. Hemobilia were caused by hepatobiliary malignancies in 29 patients and benign biliary tract diseases in the other six. Biliary obstruction caused by hemobilia was successfully ameliorated by ERCP in 34 patients. Postoperative pancreatitis ocurred in 1 patient. Conclusion The common non- iatrogenic causes of hemobilia were hepatobiliary and pancreatic malignancies. ERCP is recommended as the initial management to confirm the hemobilia and solve biliary obstruction. Key words: Hemobilia; Cholangiopancreaticography, endoscopic retrograde
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
